riTUXimab
( rit-TUCKS-ee-mab )
Other Name(s): Rituxan®; Truxima™; Riximyo™; Ruxience™; Riabni™
Apparence: Clear, colourless solution
mixed into larger bags of fluids
Les renseignements du Formulaire de médicaments s’adressent aux professionnels de la santé. Il ne s’agit pas d’un avis médical. Certains des renseignements, y compris ceux sur le financement des médicaments anticancéreux, ne s’appliquent pas à tous les patients. Les plans de traitement du cancer sont propres à chaque patient. Si vous êtes un patient, veuillez parler avec votre équipe soignante pour comprendre comment ces renseignements s’appliquent à vous.
Drug Monograph
oct 2023
Eligibility Forms
Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma Rituximab (Biosimilar IV) and Rituximab SC - Aggressive Histology Lymphoma Rituximab (Biosimilar IV) and Rituximab SC - HIV-Related Aggressive Histology B-cell Lymphoma Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma Rituximab (Biosimilar IV) and Rituximab SC - Previously Untreated Chronic Lymphocytic Leukemia Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma Rituximab (Biosimilar IV) and Rituximab SC - Second Line - Chronic Lymphocytic Leukemia Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma Rituximab (Biosimilar IV) - In Combination with Idelalisib - Relapsed Chronic Lymphocytic Leukemia Rituximab (Biosimilar IV) and Rituximab SC - In Combination with Venetoclax - Relapsed Chronic Lymphocytic Leukemia Polatuzumab Vedotin with Bendamustine and Rituximab (Biosimilar) - Relapsed or Refractory Diffuse Large B-cell Lymphoma Rituximab (Biosimilar IV) - As Part of the MATRix Regimen in Newly Diagnosed Previously Untreated PCNSL Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell LymphomaPatient Info Sheet
oct 2023
What it is used for
- For treating blood cancers such as non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL)
- Rituximab is available as a biosimilar medication. See our biosimilar pamphlet for more information.